Intercept Pharmaceuticals, Inc… (NASDAQ:ICPT)

How Intercept Pharma Shares Could See Blockbuster Drug and See Its Shares Double

Posted: March 5, 2019 at 4:08 pm

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) was last seen trading higher after the company's financial reporting. While numbers are always important to see, a more subjective issue is a positive review ...
Read Full Story »

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment

Posted: February 19, 2019 at 9:50 am

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid (OCA) in patients with liver fibrosis due ...
Read Full Story »

Why Gilead’s Pain Is Intercept’s Gain

Posted: February 12, 2019 at 9:50 am

It's another disappointing day for one of America's top biotech companies. Gilead Sciences Inc.'s (NASDAQ: GILD) selonsertib failed to improve fibrosis in the Phase 3 STELLAR-4 trial, and its shares ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BHP, Cisco, Crown Castle, Gilead, Goldcorp, Take-Two, Varonis, Whiting Petroleum and More

Posted: February 12, 2019 at 8:50 am

Stocks were indicated higher on Tuesday morning on reports that lawmakers have reached a deal to avert another partial government shutdown. While the Dow Jones industrial average is going to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AON, Conoco, Groupon, JinkoSolar, NextEra, WisdomTree, Xilinx, Yelp and More

Posted: February 4, 2019 at 8:45 am

Stocks were looking for direction on Monday morning with a light news day. Friday's small market gains put the Dow Jones industrial average up over 2,400 points from its lows ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Posted: January 31, 2019 at 8:45 am

Stocks surged higher on Wednesday after strong post-earnings reactions from Apple and Boeing, and then Federal Reserve Chair Jerome Powell helped the markets by indicating that the Fed would be ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

Posted: January 30, 2019 at 8:50 am

Stocks were indicated to open higher on Wednesday with positive earnings reactions from Apple and Boeing. Earnings season has been off to a mixed start at the start of 2019, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

Posted: November 19, 2018 at 9:00 am

  Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Boston Scientific, Etsy, GE, Morgan Stanley, SeaWorld, Skechers, Shopify, Square, Tesla and More

Posted: October 2, 2018 at 8:55 am

Stocks were taking a breather on Tuesday, but that is after the Canada trade deal sent the Dow Jones industrials up about 190 points and the S&P 500 up over ...
Read Full Story »

Even More Biopharma Catalysts Coming Through the End of March

Posted: March 17, 2018 at 7:55 am

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Posted: March 8, 2018 at 11:50 am

Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health ...
Read Full Story »

Major Biopharma Catalysts and FDA Events to Look For in March

Posted: March 3, 2018 at 8:40 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

4 Biotech Stocks to Buy for 2018 With Up to 100% Upside Potential

Posted: January 2, 2018 at 8:20 am

The new trading year is upon us, and with the holidays slowly slipping into the rear-view mirror it’s time to focus on new stocks ideas for what could prove to ...
Read Full Story »

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Posted: December 31, 2017 at 10:15 am

After a horrible 2015 and 2016, the biotechnology industry finally came back to life in 2017, shrugging off many of the issues that have clouded the waters, especially during the ...
Read Full Story »

30 Big Biotech Events Coming in 2018

Posted: December 30, 2017 at 8:55 am

Over the past year, biotech companies have more or less kept pace with the markets, but they have the potential to break out in 2018. While they have been the ...
Read Full Story »